Redeye returns with a more in-depth take on the Q2 report.
Q2'25 report Q2 was a bit softer than expected with respect to both sales and profitability.
Redeye updates its estimates and valuation after Indutrade’s Q2 2025 report.
On 15 July 2025, Føroya Banki raised its 2025 net profit guidance range to DKK 235-265m (previously ...
Redeye keeps its Base Case unchanged and makes minor estimate revisions following a Q2 report roughl...
Redeye provides an update following Episurf Medical’s Q2 2025 report, where net sales came in below ...
Consti’s Q2/2025 figures are due on Friday, July 18.
We expect double-digit earnings growth from Q4 Q2 was characterised by a stable organic performance ...
Q2 expectations Prevas will release its Q2'25 report on 17 July, and we expect SEK 428m in sales, im...
Redeye takes a more cautious approach toward the long-term prospects in Fiber Solutions, leading to ...
Ahead of Taaleri's Q2 2025 report on 13 August, we revise our estimates and slightly modify the comp...
Redeye nudges down its estimates and valuation following Lifco’s Q2 2025 report.
Redeye updates its estimates and valuation following OEM’s Q2 2025 report.
Redeye comments on Physitrack ahead of its Q2 results, due on 18 July (rescheduled from 31 July).
Two different pictures in the company While both Nordics & Baltics and the UK progressed well with p...
Ahead of Atria's Q2 report, we maintain our estimates intact.
Recycling momentum continues Nexam reported sales of SEK 54m, +1% y-o-y and -1% vs.
Redeye sees a stable Q2 report from Addnode, with the relatively solid performance in PLM being the ...
Redeye provides its initial take on OEM’s Q2 2025 report, which came in below our estimates.
Plejd rapporterade för andra kvartalet 2025 en nettoomsättning om 210,7 MSEK (146,2), motsvarande en...
